🔴 20/20 Biolabs is trading 5.45% down in after-hours trading with no confirmed company-specific catalyst

20/20 Biolabs is trading 5.45% down at $0.41 after-hours, with no confirmed company-specific announcement identified as a catalyst.

• The decline followed the September 25 regular-session close of $0.43; shares rose 2.74% during that session.
• Earlier reports covered Nasdaq listing deficiencies but do not establish a cause for the after-hours move.
• The broad market rose during the session, so it does not explain the stock’s decline.